跳至主要内容
临床试验/PACTR202112813900074
PACTR202112813900074招募中1 期

Prophylactic Cryoprecipitate Transfusion in patients undergoing Scoliosis Surgery: A randomized-controlled trial

Rabab Saber Mahrous0 个研究点目标入组 60 人开始时间: 2021年11月25日最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 18 Year(s)(—)
性别
All

入选标准

  • ASA grade I-III, adolescents who were to undergo
  • major elective scoliosis surgery expected to last at least 4 hours

排除标准

  • bleeding disorder, pre-existing thrombocytopenia
  • and/or anemia, prior thromboembolic disease, hemorrhagic diathesis, established
  • hypersensitivity to fibrinogen concentrate, active infectious disease, overweight
  • (BMI>35), left ventricular ejection fraction below 45%, significant cardiac
  • arrhythmias, valvular lesions, perioperative renal insufficiency, impaired hepatic
  • function, allergy to any drug used in this study, preoperative infection and intake of
  • acetylsalicylate within 2 weeks or nonsteroidal anti-inflammatory drugs within 7
  • days before surgery

研究者

发起方
Rabab Saber Mahrous

相似试验